ESG News For SHANGHAI NO.1 PHARMACY CO., LTD.
These sites contributed news to this page:
-
Recap of CSR stories on Business Wire
-
-
$5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company
-
The bond is tied to targets that include improving access to medicines in low- and middle-income countries (LMICs) and reducing greenhouse gas (GHG) emissions
-
Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets Wed, 11/03/2021 - 07:00 Subheader $5 billion bond is the largest of its kind from any sector and the first issued by a generic medicines company Type of Content Press Release Layout Standard Format Body TEL AVIV, Israel, November 3, 2021 /3BL Media/ - Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced ambitious commitments to address two of today’s
We use cookies to improve the usability of our site and to analyze traffic patterns so we can improve our utility. Please agree to our use of cookies.